Danaher said the Board appointed Charles W. Lamanna as a director on February February 20, 2025, with a term expiring at the 2025 annual meeting of shareholders, and also named him to the Science & Technology Committee.

1. 01

   Danaher said the Board appointed Charles W. Lamanna as a director on February February 20, 2025, with a term expiring at the 2025 annual meeting of shareholders, and also named him to the Science & Technology Committee.

2. 02

   The company said Mr. Lamanna, as a non-employee director, will receive the same compensation as Danaher's other non-employee directors, including an annual equity award, and that the Board determined he is independent under New York Stock Exchange listing standards.

3. 03

   Danaher said Mr. Lamanna has entered into a director indemnification agreement with the company. It said there is no arrangement or understanding between him and any other person under which he was selected as a director, and there are no transactions requiring disclosure under Item 404(a).

4. 04

   The company said the Board amended and restated its 2007 Omnibus Incentive Plan on February February 20, 2025, so that upon a participant's termination due to death or disability, generally all unvested stock options and restricted stock units become fully vested, and PSUs for which death or disability occurs before the performance period ends pay out the target number of shares.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.